Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Invest New Drugs ; 29(4): 523-33, 2011 Aug.
Article in English | MEDLINE | ID: mdl-20069337

ABSTRACT

DNA intercalating molecules are promising chemotherapeutic agents. In the present study, a novel DNA intercalating compound of pyrimido[4',5':4,5]selenolo(2,3-b)quinoline series having 8-methyl-4-(3 diethylaminopropylamino) side chain is studied for its chemotherapeutic properties. Our results showed that 8-methyl-4-(3 diethylaminopropylamino) pyrimido [4',5':4,5] selenolo(2,3-b)quinoline (MDPSQ) induces cytotoxicity in a time- and concentration-dependent manner on leukemic cell lines. Both cell cycle analysis and tritiated thymidine assays revealed that MDPSQ affects DNA replication. Treatment with MDPSQ resulted in both elevated levels of DNA strand breaks and repair proteins, further indicating its cytotoxic effects. Besides, Annexin V/PI staining revealed that MDPSQ induces cell death by triggering necrosis rather than apoptosis.


Subject(s)
Alkaloids/chemistry , Alkaloids/pharmacology , Ellipticines/chemistry , Ellipticines/pharmacology , Leukemia/pathology , Necrosis/chemically induced , Organoselenium Compounds/pharmacology , Annexin A5/metabolism , Apoptosis/drug effects , Biological Transport/drug effects , Cell Cycle/drug effects , Cell Death/drug effects , Cell Line, Tumor , Cell Membrane/drug effects , Cell Membrane/metabolism , Cell Proliferation/drug effects , Cell Survival/drug effects , DNA Fragmentation/drug effects , DNA Repair/drug effects , DNA Replication/drug effects , DNA, Neoplasm/biosynthesis , Drug Screening Assays, Antitumor , Genomic Instability/drug effects , Humans , Necrosis/pathology , Neoplasm Proteins/metabolism , Organoselenium Compounds/chemistry , Phosphatidylserines/metabolism , Propidium/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...